RASAGILINE vs RAVULIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RASAGILINE vs RAVULIZUMAB: Safety Overview
| Metric | RASAGILINE | RAVULIZUMAB |
|---|---|---|
| Total FAERS Reports | 2,731 | 118 |
| Deaths Reported | 255 | 11 |
| Death Rate | 9.3% | 9.3% |
| Hospitalizations | 961 | 89 |
| Average Patient Age | 71.0 yrs | 48.4 yrs |
| % Female Patients | 46.2% | 56.3% |
| FDA Approval Date | Apr 9, 2024 | N/A |
| Manufacturer | Ascend Laboratories, LLC | Alexion Pharmaceuticals Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | N/A |